Companies

Moderna Posts $1.2 Billion Loss as Sales of COVID-19 Vaccine Plunge 94 Percent

Moderna Posts $1.2 Billion Loss as Sales of COVID-19 Vaccine Plunge 94 Percent
Two vials of COVID-19 Moderna vaccines. Hazem Bader/AFP via Getty Images
Tom Ozimek
Tom Ozimek
Reporter
|Updated:
0:00

Moderna posted a $1.2 billion loss in the first quarter of 2024, with the drugmaker blaming crashing sales of its COVID-19 vaccine.

The company notched $167 million in first-quarter sales of its COVID-19 vaccine (called Spikevax), according to a May 2 earnings report. That’s a 94 percent drop from the $2.8 billion in the prior quarter.

Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics